Homology Medicines' Corporate Minority Round

Homology Medicines raised a round of funding on November 14, 2017. Investors include Novartis.

Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into treatments for patients with rare diseases.…

Articles about Homology Medicines' Corporate Minority Round: